Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 1.00 |
| ▸ | DPP7 | Q9UHL4 | 18/20 | 1.00 |
| ▸ | DPP8 | Q6V1X1 | 15/20 | 1.00 |
| ▸ | DPP9 | Q86TI2 | 14/20 | 1.00 |
| ▸ | FAP | Q12884 | 13/20 | 1.00 |
| ▸ | PITRM1 | Q5JRX3 | 5/20 | 1.00 |
| ▸ | PREP | P48147 | 4/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Talabostat SCHEMBL14160935 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL14160999 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL21156686 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL6895250 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL14160998 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL12185345 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL4320843 | 1.00 | DPP4 (1.00) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL23070729 | 0.93 | DPP4 (0.86) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL7417653 | 0.93 | DPP4 (0.86) | DPP4DPP7DPP8DPP9FAP | |
| Talabostat SCHEMBL4782073 | 0.93 | DPP4 (0.86) | DPP4DPP7DPP8DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12419 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121424416-B | Multi-station transfer manipulator cooperative control system based on computer control | NANTONG SHUNXIANG STEEL STRUCTURE Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122087326-A | Multi-source data and dynamic period attention improvement FSLSTM icing prediction method | — | 2026-05-26 | — | — | CN | claimed |
| CN-224271193-U | Heating tank for producing biological aviation kerosene raw material by utilizing waste edible oil | Zhejiang Fuze New Energy Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122086298-A | Wen Zhen electric integrated data acquisition card triggered by multiple signals selectively | — | 2026-05-26 | — | — | CN | claimed |
| CN-224270810-U | Camel lamb milk powder agitating unit | Beijing aonaier Feed Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-224277547-U | Frost crack preventing protector for ship air conditioner pipeline | Anrong Energy Technology (Shandong) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122075827-A | Intelligent enema device for senile incomplete intestinal obstruction | — | 2026-05-26 | — | — | CN | claimed |
| CN-122086154-A | Intelligent constant temperature and constant pressure control system for clean laboratory | — | 2026-05-26 | — | — | CN | claimed |
| CN-122093868-A | Metallurgical remote control rail locomotive operation data 4G real-time transmission system | — | 2026-05-26 | — | — | CN | claimed |
| CN-122090566-A | Property equipment abnormity automatic alarm system based on multi-sensor fusion | — | 2026-05-26 | — | — | CN | claimed |
| EP-2004157-B1 | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AS WELL AS COMBINATION THERAPY RELATING THERETO | ARENA PHARM INC (US) | 2011-01-12 | — | — | EP | claimed |
| EP-2253311-A2 | Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto | Arena Pharmaceuticals, Inc. (US) | 2010-11-24 | — | — | EP | claimed |
| US-20100190750-A1 | GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto | ARENA PHARMACEUTICALS, INC. (US) | 2010-07-29 | — | — | US | claimed |
| EP-1911756-B9 | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | ARENA PHARM INC (US) | 2010-05-26 | — | — | EP | claimed |
| EP-1911756-B1 | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | ARENA PHARM INC (US) | 2009-10-21 | — | — | EP | claimed |
| EP-0960127-A4 | ISOLATED DIMERIC FIBROBLAST ACTIVATION PROTEIN ALPHA, AND USES THEREOF | LUDWIG INST CANCER RES (US) | 2004-09-08 | — | — | EP | claimed |
| EP-0960127-A1 | ISOLATED DIMERIC FIBROBLAST ACTIVATION PROTEIN ALPHA, AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1999-12-01 | — | — | EP | claimed |
| WO-1997034927-A1 | ISOLATED DIMERIC FIBROBLAST ACTIVATION PROTEIN ALPHA, AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-09-25 | — | — | WO | claimed |
| EP-0641347-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1995-03-08 | — | — | EP | claimed |
| WO-1993010127-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1993-05-27 | — | — | WO | claimed |